- Issuer ticker
-
TLSA
- Reported as of
-
18 Mar 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
3
- Accepted by SEC
-
22 May 2026, 16:55:33 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Keeren Shah
Key filing fact
Keeren Rameshchandra Shah filed Form 3 for Tiziana Life Sciences Ltd (TLSA) on 22 May 2026.
Key facts
- This page summarizes Keeren Rameshchandra Shah's Form 3 filing for Tiziana Life Sciences Ltd (TLSA).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 16:55.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0002125071
Primary reporting owner
Shah Keeren Rameshchandra
- Relationship
-
CHIEF OPERATING & FIN. OFFICER
- Address
- C/O TIZIANA LIFE SCIENCES LTD, 14-15 CONDUIT STREET, LONDON, UNITED KINGDOM
- Signature
- /s/ Keeren Shah
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLSA
holding
COMMON STOCK
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 2,500
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 15,625
- Exercise price
- $0.8800
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 46,875
- Exercise price
- $0.5700
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 83,333
- Exercise price
- $0.5000
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 83,334
- Exercise price
- $0.5000
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 125,000
- Exercise price
- $0.8200
TLSA
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 12,500
- Exercise price
- $1.58
* marks a reported price that did not pass the local price check.